Further analysis revealed that this is mainly evidenced by its upregulation of PD-L1 expression in tumor cells as well as in tumor-infiltrating immune cells, which plays an important role in the development of late adaptive mechanisms of immune resistance to increased immune cell infiltration into tumors (146). The gene discussed is CD274; the disease is neoplasm.